Will Reports of More Potential Pfizer Acquisitions Affect AbbVie Stock Today?

NEW YORK (TheStreet) -- Shares of AbbVie  were down 1.16% to $57.32 in morning trading Friday despite reports that pharmaceutical giant Pfizer   could pursue more acquisitions after its $17 billion purchase of Hospira . Pfizer unsuccessfully sought a nearly $120 billion merger with AstraZeneca last year, and its acquisition of Hospira comes at just a fraction of that cost. Pfizer therefore has room to make more acquisitions, and CEO Ian Read said the company continues to look at more opportu...